Neuronal activity regulates the regional vulnerability to amyloid-β deposition

Adam W Bero, Ping Yan, Jee Hoon Roh, John R Cirrito, Floy R Stewart, Marcus E Raichle, Jin-Moo Lee, David M Holtzman, Adam W Bero, Ping Yan, Jee Hoon Roh, John R Cirrito, Floy R Stewart, Marcus E Raichle, Jin-Moo Lee, David M Holtzman

Abstract

Amyloid-β (Aβ) plaque deposition in specific brain regions is a pathological hallmark of Alzheimer's disease. However, the mechanism underlying the regional vulnerability to Aβ deposition in Alzheimer's disease is unknown. Herein, we provide evidence that endogenous neuronal activity regulates the regional concentration of interstitial fluid (ISF) Aβ, which drives local Aβ aggregation. Using in vivo microdialysis, we show that ISF Aβ concentrations in several brain regions of APP transgenic mice before plaque deposition were commensurate with the degree of subsequent plaque deposition and with the concentration of lactate, a marker of neuronal activity. Furthermore, unilateral vibrissal stimulation increased ISF Aβ, and unilateral vibrissal deprivation decreased ISF Aβ and lactate, in contralateral barrel cortex. Long-term unilateral vibrissal deprivation decreased amyloid plaque formation and growth. Our results suggest a mechanism to account for the vulnerability of specific brain regions to Aβ deposition in Alzheimer's disease.

Figures

Figure 1
Figure 1
Distribution of Aβ and amyloid plaque deposition in Tg2576 mouse brain. (a,b) Representative brain sections from aged (17.5 ± 0.5 months old) Tg2576 mice stained with biotinylated-3D6 antibody (anti Aβ1–5) to visualize Aβ immunopositive plaques (n = 7 per group). Scale bar, 750 μM. (c) A stepwise increase in percent brain area occupied by Aβ deposition was present across barrel (BC), cingulate (CC) and piriform (PC) cortices. Aβ plaque burden in hippocampus (HC) was similar to barrel cortex while striatum (ST) exhibited the lowest level of plaque deposition of all regions examined (one-way ANOVA, Tukey’s post hoc test for multiple comparisons). (dh) Representative images of barrel cortex (d), cingulate cortex (e), piriform cortex (f), hippocampus (g) and striatum (h) of aged Tg2576 mice stained with the amyloid binding dye, X-34 (n = 6 per group). Scale bar, 50 μM. (i) Percent area occupied by X-34 positive amyloid deposition was greater in piriform cortex compared to all other brain regions examined. A stepwise increase in amyloid deposition was present across barrel, cingulate and piriform cortices. Amyloid plaque burden in hippocampus was similar to barrel cortex while X-34 positive staining was not detected in striatum (one-way ANOVA, Tukey’s post hoc test for multiple comparisons). **, P < 0.01; ***, P < 0.001. Values represent mean ± SEM.
Figure 2
Figure 2
Steady-state ISF Aβ levels in young Tg2576 mice prior to plaque deposition are associated with the level of region-specific plaque deposition in aged Tg2576 mice. (a) In vivo microdialysis was performed to measure the steady-state concentration of ISF Aβx-40 in barrel cortex (BC), piriform cortex (PC), hippocampus (HC) and striatum (ST) of 3.5 ± 0.5 month-old Tg2576 mice prior to the onset of plaque deposition (n = 5–6 per group; one-way ANOVA, Tukey’s post hoc test for multiple comparisons). Steady-state levels of ISF Aβx-40 measured in each brain region of young Tg2576 mice were closely associated with the level of subsequent Aβ (b) and amyloid (c) plaque deposition in each brain region of aged Tg2576 mice. (d) In vivo microdialysis was performed to measure the steady-state concentration of ISF Aβx-42 in barrel cortex, piriform cortex, hippocampus and striatum of 3.5 ± 0.5 month-old Tg2576 mice prior to the onset of plaque deposition (n = 5–8 per group; one-way ANOVA, Tukey’s post hoc test for multiple comparisons). Steady-state levels of ISF Aβx-42 measured in each brain region of young Tg2576 mice were closely associated with the level of subsequent Aβ (e) and amyloid (f) plaque deposition in each brain region of aged Tg2576 mice. ◇, striatum; ■, barrel cortex, ○, hippocampus; ●, piriform cortex. *, P < 0.05; **, P < 0.01; ***, P < 0.001. Values represent mean ± SEM.
Figure 3
Figure 3
Neuronal activity regulates ISF lactate concentration in vivo. (a) Representative intraparenchymal EEG recordings from hippocampus of young Tg2576 mice during basal conditions, picrotoxin (PTX; 12.5 μM) treatment or tetrodotoxin (TTX; 5 μM) treatment via in vivo microdialysis (n = 4 per group). (b) Local PTX infusion increased ISF lactate levels and local TTX infusion decreased ISF lactate levels in hippocampus of young Tg2576 mice (n = 4 per group; two-tailed t-test). (c) Local PTX infusion increased ISF Aβx-40 levels and local TTX infusion decreased ISF Aβx-40 levels in hippocampus of young Tg2576 mice (n = 4 per group; two-tailed t-test). Values in b,c represent analyte levels during the final 6 hours of drug treatment. (d) ISF lactate levels were correlated with ISF Aβx-40 levels across treatment periods (Pearson r = 0.7645; P < 0.0001). *, P < 0.05; **, P < 0.01. Values represent mean ± SEM.
Figure 4
Figure 4
Steady-state ISF lactate levels in young Tg2576 mice are closely associated with regional ISF Aβ levels in young Tg2576 mice and plaque deposition in aged Tg2576 mice. (a–d) In vivo microdialysis was performed to measure steady-state ISF lactate levels in barrel cortex, piriform cortex, hippocampus and striatum of young Tg2576 mice (n = 6–7 per group). ISF lactate level in each brain region was closely associated with the concentration of ISF Aβx-40 (a) and ISF Aβx-42 (b) in each brain region of young Tg2576 mice. ISF lactate level in each brain region of young Tg2576 mice was also closely associated with the level of Aβ (c) and amyloid (d) plaque deposition in each brain region of aged Tg2576 mice. ◇, striatum; ■, barrel cortex, ○, hippocampus; ●, piriform cortex. Values represent mean ± SEM.
Figure 5
Figure 5
Vibrissal activity regulates ISF Aβ levels in vivo. (ac) In vivo microdialysis was performed in posterior barrel cortex of young Tg2576 mice. After establishing stable basal ISF Aβx-40 and lactate levels, all vibrissae contralateral to the microdialysis probe were trimmed to within 1 mm of the facial pad and microdialysis sample collection continued for 16 hr to determine the effect of vibrissae deprivation on ISF Aβx-40 and lactate levels in barrel cortex. Vibrissae deprivation decreased ISF Aβx-40 (a, ■ in c) and lactate (b, □ in c) levels relative to baseline (n = 6–7; two-tailed t-test). (d) In vivo microdialysis was performed in barrel cortex in a separate cohort of young Tg2576 mice that underwent subsequent unilateral vibrissae stimulation. Baseline Aβx-40 values were obtained for a 30 minute period. Unilateral mechanical stimulation of vibrissae contralateral to the microdialysis probe (5–7 Hz, 4 s burst, 4 s inter-burst interval) was performed for 30 minutes. Vibrissae stimulation increased ISF Aβx-40 levels compared to control conditions (n = 4; two-tailed t-test). *, P < 0.05; **, P < 0.01. Values represent mean ± SEM.
Figure 6
Figure 6
Diurnal fluctuation of ISF Aβ is closely associated with ISF lactate levels. (ac) In vivo microdialysis was performed in hippocampus of young Tg2576 mice housed in 12 hour light/12 hour dark conditions. ISF Aβ1-x levels exhibited diurnal fluctuation (a) and were significantly greater in the dark period compared to the light period (■ in c; n = 6; two-tailed t-test). ISF lactate levels also exhibited diurnal fluctuation (b) and were significantly greater in the dark period compared to the light period (□ in c; n = 6; two-tailed t-test). (d) ISF Aβ1-x levels were correlated with ISF lactate levels throughout the sleep/wake cycle (Pearson r = 0.6351; P < 0.0001). *, P < 0.05; **, P < 0.01. Values represent mean ± SEM.
Figure 7
Figure 7
Vibrissae deprivation reduces amyloid plaque growth and formation in vivo. (a,b) Representative multiphoton micrographs of individual amyloid plaques in barrel cortex in control hemisphere of APP/PS1 mice before (a) and after (b) 28 days of unilateral vibrissae deprivation. (c,d) Representative multiphoton micrographs of amyloid plaques in barrel cortex in vibrissae-deprived hemisphere of APP/PS1 mice before (c) and after (d) 28 days of vibrissae deprivation. (e) Long-term vibrissae deprivation decreased existing amyloid plaque growth compared to the control hemisphere (n = 6 mice; two-tailed t-test). (f) Long-term vibrissae deprivation also reduced new plaque formation compared to the control hemisphere (n = 6 mice; two-tailed t-test). ↑, existing amyloid plaque; △, newly formed amyloid plaque. Scale bar, 50 μM; *, P < 0.05; **, P < 0.01. Values represent mean ± SEM.

References

    1. Selkoe DJ. Alzheimer’s disease: genes, proteins, and therapy. Physiol Rev. 2001;81:741–766.
    1. Cirrito JR, et al. In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life. J Neurosci. 2003;23:8844–8853.
    1. Meyer-Luehmann M, et al. Extracellular amyloid formation and associated pathology in neural grafts. Nat Neurosci. 2003;6:370–377.
    1. Yan P, et al. Characterizing the appearance and growth of amyloid plaques in APP/PS1 mice. J Neurosci. 2009;29:10706–10714.
    1. Raichle ME, et al. A default mode of brain function. Proc Natl Acad Sci U S A. 2001;98:676–682.
    1. Buckner RL, et al. Molecular, structural, and functional characterization of Alzheimer’s disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci. 2005;25:7709–7717.
    1. Buckner RL, Andrews-Hanna JR, Schacter DL. The brain’s default network: anatomy, function, and relevance to disease. Ann N Y Acad Sci. 2008;1124:1–38.
    1. Buckner RL, et al. Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer’s disease. J Neurosci. 2009;29:1860–1873.
    1. Vaishnavi SN, et al. Regional aerobic glycolysis in the human brain. Proc Natl Acad Sci U S A. 2010;107:17757–17762.
    1. Vlassenko AG, et al. Spatial correlation between brain aerobic glycolysis and amyloid-beta (Abeta ) deposition. Proc Natl Acad Sci U S A. 2010;107:17763–17767.
    1. Greicius MD, Srivastava G, Reiss AL, Menon V. Default-mode network activity distinguishes Alzheimer’s disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci U S A. 2004;101:4637–4642.
    1. Hedden T, et al. Disruption of functional connectivity in clinically normal older adults harboring amyloid burden. J Neurosci. 2009;29:12686–12694.
    1. Sperling RA, et al. Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron. 2009;63:178–188.
    1. Hyder F, et al. Neuronal-glial glucose oxidation and glutamatergic-GABAergic function. J Cereb Blood Flow Metab. 2006;26:865–877.
    1. Kamenetz F, et al. APP processing and synaptic function. Neuron. 2003;37:925–937.
    1. Wei W, et al. Amyloid beta from axons and dendrites reduces local spine number and plasticity. Nat Neurosci. 2010;13:190–196.
    1. Cirrito JR, et al. Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron. 2005;48:913–922.
    1. Cirrito JR, et al. Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo. Neuron. 2008;58:42–51.
    1. Hsiao K, et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science. 1996;274:99–102.
    1. Pellerin L, Magistretti PJ. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci U S A. 1994;91:10625–10629.
    1. Uehara T, Sumiyoshi T, Itoh H, Kurata K. Lactate production and neurotransmitters; evidence from microdialysis studies. Pharmacol Biochem Behav. 2008;90:273–281.
    1. Woolsey TA, Van der Loos H. The structural organization of layer IV in the somatosensory region (SI) of mouse cerebral cortex. The description of a cortical field composed of discrete cytoarchitectonic units. Brain Res. 1970;17:205–242.
    1. Melzer P, et al. A magnetic device to stimulate selected whiskers of freely moving or restrained small rodents: its application in a deoxyglucose study. Brain Res. 1985;348:229–240.
    1. Durham D, Woolsey TA. Acute whisker removal reduces neuronal activity in barrels of mouse SmL cortex. J Comp Neurol. 1978;178:629–644.
    1. Rojas MJ, Navas JA, Rector DM. Evoked response potential markers for anesthetic and behavioral states. Am J Physiol Regul Integr Comp Physiol. 2006;291:R189–196.
    1. Kang JE, et al. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science. 2009;326:1005–1007.
    1. Riedner BA, et al. Sleep homeostasis and cortical synchronization: III. A high-density EEG study of sleep slow waves in humans. Sleep. 2007;30:1643–1657.
    1. Vyazovskiy VV, Cirelli C, Pfister-Genskow M, Faraguna U, Tononi G. Molecular and electrophysiological evidence for net synaptic potentiation in wake and depression in sleep. Nat Neurosci. 2008;11:200–208.
    1. Gilestro GF, Tononi G, Cirelli C. Widespread changes in synaptic markers as a function of sleep and wakefulness in Drosophila. Science. 2009;324:109–112.
    1. Jankowsky JL, et al. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet. 2004;13:159–170.
    1. Bahmanyar S, et al. Localization of amyloid beta protein messenger RNA in brains from patients with Alzheimer’s disease. Science. 1987;237:77–80.
    1. Goedert M. Neuronal localization of amyloid beta protein precursor mRNA in normal human brain and in Alzheimer’s disease. EMBO J. 1987;6:3627–3632.
    1. Vassar R, et al. Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE. Science. 1999;286:735–741.
    1. Page K, Hollister R, Tanzi RE, Hyman BT. In situ hybridization analysis of presenilin 1 mRNA in Alzheimer disease and in lesioned rat brain. Proc Natl Acad Sci U S A. 1996;93:14020–14024.
    1. Irizarry MC, McNamara M, Fedorchak K, Hsiao K, Hyman BT. APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1. J Neuropathol Exp Neurol. 1997;56:965–973.
    1. Irizarry MC, Locascio JJ, Hyman BT. beta-site APP cleaving enzyme mRNA expression in APP transgenic mice: anatomical overlap with transgene expression and static levels with aging. Am J Pathol. 2001;158:173–177.
    1. Bigl M, et al. Expression of beta-secretase mRNA in transgenic Tg2576 mouse brain with Alzheimer plaque pathology. Neurosci Lett. 2000;292:107–110.
    1. Goldstein ME, et al. Ex vivo occupancy of gamma-secretase inhibitors correlates with brain beta-amyloid peptide reduction in Tg2576 mice. J Pharmacol Exp Ther. 2007;323:102–108.
    1. Meyer-Luehmann M, et al. Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science. 2006;313:1781–1784.
    1. Eisele YS, et al. Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis. Science. 2010;330:980–982.
    1. Harris JA, et al. Transsynaptic progression of amyloid-beta-induced neuronal dysfunction within the entorhinal-hippocampal network. Neuron. 2010;68:428–441.
    1. Lazarov O, Lee M, Peterson DA, Sisodia SS. Evidence that synaptically released beta-amyloid accumulates as extracellular deposits in the hippocampus of transgenic mice. J Neurosci. 2002;22:9785–9793.
    1. Filippini N, et al. Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc Natl Acad Sci U S A. 2009;106:7209–7214.
    1. Kim J, Basak JM, Holtzman DM. The role of apolipoprotein E in Alzheimer’s disease. Neuron. 2009;63:287–303.
    1. Flicker L. Modifiable lifestyle risk factors for Alzheimer’s disease. J Alzheimers Dis. 2010;20:803–811.
    1. Olney JW, Wozniak DF, Farber NB. Excitotoxic neurodegeneration in Alzheimer disease. New hypothesis and new therapeutic strategies. Arch Neurol. 1997;54:1234–1240.
    1. Kim J, et al. Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular A beta clearance. Neuron. 2009;64:632–644.
    1. Franklin KB, Paxinos G. The Mouse Brain in Stereotaxic Coordinates. Academic Press; San Diego: 1996.
    1. Klunk WE, et al. Imaging Abeta plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative. J Neuropathol Exp Neurol. 2002;61:797–805.

Source: PubMed

3
Abonneren